Sergio G. Duron
27Patents
7h-index
34Co-inventors
65Inventor score
Filing activity: Oct 25, 2005 → May 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8399018B2 | Controlled release ion channel modulator compositions and methods for the treatment of otic disorders | Human Necessities | 36 | Active |
| US8846770B2 | Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders | Human Necessities | 32 | Active |
| US8784870B2 | Controlled release compositions for modulating free-radical induced damage and methods of use thereof | Human Necessities | 32 | Active |
| US8496957B2 | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders | Human Necessities | 25 | Active |
| US9333171B2 | Controlled-release CNS modulating compositions and methods for the treatment of otic disorders | Human Necessities | 7 | Active |
| US10272034B2 | Auris formulations for treating otic diseases and conditions | Chemistry; Metallurgy | 7 | Active |
| US9427472B2 | Controlled release compositions for modulating free-radical induced damage and methods of use thereof | Human Necessities | 7 | Active |
| US10092580B2 | Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders | Human Necessities | 7 | Active |
| US7517884B2 | Sulfonyl-substituted bicyclic compounds as modulators of PPAR | Chemistry; Metallurgy | 4 | Active |
| US11548892B1 | Transglutaminase 2 (TG2) inhibitors | Chemistry; Metallurgy | 3 | Active |
| US7494999B2 | Sulfonyl-substituted bicyclic compounds as modulators of PPAR | Chemistry; Metallurgy | 3 | Expired |
| US8680083B2 | Controlled release corticosteroid compositions and methods for the treatment of otic disorders | Human Necessities | 2 | Active |
| US8680099B2 | 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | Human Necessities | 2 | Active |
| US8674095B2 | Compounds for treating neuropsychiatric conditions | Chemistry; Metallurgy | 2 | Active |
| US10501493B2 | Broad spectrum antibiotics | Emerging Cross-Sectional Technologies | 2 | Active |
| US8372970B2 | 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | Human Necessities | 2 | Active |
| US8680082B2 | Controlled release corticosteroid compositions and methods for the treatment of otic disorders | Human Necessities | 2 | Active |
| US10227314B2 | Cystathionine-gamma-lyase (CSE) inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8912203B2 | 6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | Physics | 1 | Active |
| US7834004B2 | Sulfonyl-substituted bicyclic compounds as modulators of PPAR | Chemistry; Metallurgy | 1 | Active |
| US9725426B2 | Cystathionine-γ-lyase (CSE) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7915253B2 | Sulfonyl-substituted bicyclic compounds as modulators of PPAR | Chemistry; Metallurgy | 0 | Active |
| US10918594B2 | Controlled-release CNS modulating compositions and methods for the treatment of otic disorders | Human Necessities | 0 | Active |
| US9771339B2 | Cystathionine-γ-lyase (CSE) inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12152026B2 | Transglutaminase 2 (TG2) inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.